ストックスクリーナーアプリを入手
0.00
100.00%
-59.98
アフターアワーズ：
60.01
60.01
+
前日終値:
$59.98
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$2.34B
収益：
-
当期純損益:
$-76.34M
株価収益率:
0.00
EPS:
-2.23
ネットキャッシュフロー:
$-65.93M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$60.03
Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile
名前
Longboard Pharmaceuticals Inc
セクター
電話
619-592-9775
住所
4275 EXECUTIVE SQUARE, LA JOLLA
LBPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LBPH
Longboard Pharmaceuticals Inc
|
0.00 | 2.34B | 0 | -76.34M | -65.93M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-10 | 開始されました | Truist | Buy |
| 2024-07-01 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2024-05-01 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-16 | 開始されました | Citigroup | Buy |
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-04-27 | 開始されました | B. Riley Securities | Buy |
| 2021-04-07 | 開始されました | Evercore ISI | Outperform |
| 2021-04-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-06 | 開始されました | Citigroup | Buy |
| 2021-04-06 | 開始されました | Guggenheim | Buy |
すべてを表示
Longboard Pharmaceuticals Inc (LBPH) 最新ニュース
Dealmaking Quarterly Statistics, Q4 2024 - Citeline News & Insights
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - GlobeNewswire
Jane Street Group LLC Cuts Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Geode Capital Management LLC Raises Stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Barclays PLC Acquires 38,669 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Acquired by State Street Corp - Defense World
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Longboard Pharmaceuticals' SWOT analysis: bexicaserin potential drives stock outlook - Investing.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.84 Million Stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN
Longboard Pharmaceuticals' SWOT analysis: bexicaserin stock poised for growth - Investing.com
Vincent Aurentz Joins Forward Therapeutics' Board of Directors - PR Newswire
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Sold by Quantbot Technologies LP - MarketBeat
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INSI, LBPH, NBR on Behalf of Shareholders - The Eastern Progress Online
Readystate Asset Management LP Makes New Investment in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Lundbeck to present data at epilepsy congress - Marketscreener.com
Parkman Healthcare Partners LLC Sells 202,906 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Fmr LLC Has $144.99 Million Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Lundbeck acquires all outstanding shares of Longboard Pharma - MSN
Longboard Pharmaceuticals concludes merger with H. Lundbeck A/S By Investing.com - Investing.com Australia
Longboard Pharmaceuticals concludes merger with H. Lundbeck A/S - Investing.com
Lundbeck completes billion dollar acquisition of Longboard Pharmaceuticals - Marketscreener.com
Langkawi Corporation completed the acquisition of Longboard Pharmaceuticals, Inc.. - Marketscreener.com
Victory Capital Management Inc. Invests $526,000 in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Victory Capital Management Inc. Buys New Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Purchased by Ally Bridge Group NY LLC - MarketBeat
Lundbeck's acquisition conditions for Longboard have been met, closing the deal on December 2 - Marketscreener.com
Longboard Pharmaceuticals stock soars to all-time high of $59.96 By Investing.com - Investing.com Nigeria
Longboard Pharmaceuticals stock soars to all-time high of $59.96 - Investing.com
Bright Minds Buosciences Surges 5,900% Last Week. Attention Turning To Cybin ($CYBN) Rallying 23% On Upcoming... - Daily Scanner
Bright Minds initiated at outperform by Baird, Longboard takeover cited (NASDAQ:DRUG) - Seeking Alpha
KBC Group NV Acquires New Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Jennison Associates LLC Sells 34,440 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Brokerages Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Price Target at $59.56 - MarketBeat
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH - GlobeNewswire Inc.
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage - MSN
299,156 Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Bought by Braun Stacey Associates Inc. - MarketBeat
Longboard Pharmaceuticals Initiates Phase 3 DEEp Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies - Marketscreener.com
LBPHLongboard Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs) - Business Wire
Longboard Pharmaceuticals Advances Neurological Treatments - TipRanks
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
FMR LLC Reduces Stake in Longboard Pharmaceuticals Inc - GuruFocus.com
How the (LBPH) price action is used to our Advantage - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com
Longboard Pharmaceuticals granted Orphan Drug Designation for bexicaserin - TipRanks
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat
Longboard Pharmaceuticals Inc (LBPH) 財務データ
収益
当期純利益
現金流量
EPS
1.39%
0.55%
大文字化:
|
ボリューム (24 時間):